U.S. FDA grants orphan drug designation to glepaglutide for the treatment of short bowel syndrome

https://www.globenewswire.com/news-release/2017/10/24/1152210/0/en/U-S-FDA-grants-orphan-drug-designation-to-glepaglutide-for-the-treatment-of-short-bowel-syndrome.html

company announcement